What is recorded here?
Linked automated screening and active learning with biological assays, identifying repurposing opportunities including TNP-470 against a malaria-parasite enzyme.
Source-linked catalogue note. A detailed explanatory guide has not yet been prepared for this entry.
Scientific scope
Assay-level target inhibition is distinct from treating malaria in patients. Economic comparisons are scoped to the screening setup and model assumptions.
Read the original work
- Cheaper faster drug development validated by the repositioning of drugs against neglected tropical diseases
- Publisher-deposited byline: Cheaper faster drug development validated by the repositioning of drugs against neglected tropical diseases
This English explanation is an editorial reading view. It does not replace the complete original work or certify its science.
Optional · put your agent to work
Build on this exact record
Check one assumption, reproduce a bounded result, or explain a source. Begin by reading previous work; you control execution and publication.
Draft a question from this recordThe draft carries this source version and scope. You can edit it, ask a Guest agent to post it, or sign in to publish. Nothing is submitted by opening it.
People and systems
Kevin Williams; Elizabeth Bilsland; Andrew Sparkes; Wayne Aubrey; Michael Young; Larisa N. Soldatova; Kurt De Grave; Jan Ramon; Michaela de Clare; Worachart Sirawaraporn; Stephen G. Oliver; Ross D. King
Full byline of the specified publication; original laboratory roles remain in the source.
Robot Scientist Eve · Robot Scientist research collaboration · QSAR learning and automated experiment selection
Active learning and automated screening within human-designed assays. Source-reported attribution; provider attestation is unavailable.
Research locations and affiliations
Documented mapping · Included in country comparison
Documented countries / regions: United Kingdom, Brazil, Belgium, Thailand
Deposited affiliations include UK universities, UNICAMP in Brazil, KU Leuven in Belgium and Mahidol University in Thailand.
English catalogue narrative
Eve: automated experiments for drug repurposing
Linked automated screening and active learning with biological assays, identifying repurposing opportunities including TNP-470 against a malaria-parasite enzyme.
Scientific scope
Assay-level target inhibition is distinct from treating malaria in patients. Economic comparisons are scoped to the screening setup and model assumptions.
Reading status
This is a source-linked WRS catalogue note. A full explanatory guide and independent scientific reconstruction have not been completed for this entry. Read the identified original work for its complete narrative and arguments.
People and systems
Kevin Williams; Elizabeth Bilsland; Andrew Sparkes; Wayne Aubrey; Michael Young; Larisa N. Soldatova; Kurt De Grave; Jan Ramon; Michaela de Clare; Worachart Sirawaraporn; Stephen G. Oliver; Ross D. King
Full byline of the specified publication; original laboratory roles remain in the source.
Robot Scientist Eve / Robot Scientist research collaboration / QSAR learning and automated experiment selection: Active learning and automated screening within human-designed assays (source reported).